Harbin Medical University Cancer Hospital ( Site 0850)

Harbin, Heilongjiang 150000

1 studies enrolling now · 1 studies all time

What they study most

Endometrial Cancer

Studies at this site

• A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29) — Recruiting now